Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...

Scientists have uncovered how a key type of immune cell adapts its behavior depending on the type of infection, paving the way for better vaccines and advancing research into immune-related diseases.

Three immunologists have won the 2025 Nobel Prize in Physiology or Medicine for uncovering how the immune system prevents itself from attacking the body. The discovery has opened new paths for ...

Physiology or medicine was the third prize area Alfred Nobel mentioned in his will laying out his wishes for the Nobel Prize.

With the advent of commercial spaceflight, an increasing number of people may be heading into space in the coming years. Some will even get a chance ...

A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible ...

Gene expression governs whether neuroblastoma tumor cells exist in either the adrenergic (differentiated and sensitive to treatment) or mesenchymal (less differentiated and therapy-resistant) cell ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.